1. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005; 365:2125–36.

2. Charmandari E, Chrousos GP. Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? Ann N Y Acad Sci. 2006; 1083:37–53.

3. Torky A, Sinaii N, Jha S, Desai J, El-Maouche D, Mallappa A, et al. Cardiovascular disease risk factors and metabolic morbidity in a longitudinal study of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2021; 106:e5247–57.

4. Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018; 103:4043–88.

5. Chrysostomou PP, Lodish MB, Turkbey EB, Papadakis GZ, Stratakis CA. Use of 3-dimensional volumetric modeling of adrenal gland size in patients with primary pigmented nodular adrenocortical disease. Horm Metab Res. 2016; 48:242–6.

6. Degenhart C, Schneller J, Osswald A, Pallauf A, Riester A, Reiser MF, et al. Volumetric and densitometric evaluation of the adrenal glands in patients with primary aldosteronism. Clin Endocrinol (Oxf). 2017; 86:325–31.

7. Godoy-Matos AF, Vieira AR, Moreira RO, Coutinho WF, Carraro LM, Moreira DM, et al. The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diabetes. J Endocrinol Invest. 2006; 29:159–63.

8. Vincent JM, Morrison ID, Armstrong P, Reznek RH. The size of normal adrenal glands on computed tomography. Clin Radiol. 1994; 49:453–5.

9. Wang X, Jin ZY, Xue HD, Liu W, Sun H, Chen Y, et al. Evaluation of normal adrenal gland volume by 64-slice CT. Chin Med Sci J. 2013; 27:220–4.

10. Auchus RJ, Arlt W. Approach to the patient: the adult with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2013; 98:2645–55.

11. Turcu AF, Mallappa A, Elman MS, Avila NA, Marko J, Rao H, et al. 11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2017; 102:2701–10.

12. Reisch N, Scherr M, Flade L, Bidlingmaier M, Schwarz HP, Muller-Lisse U, et al. Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2010; 95:2065–72.

13. Rivkees SA, Crawford JD. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics. 2000; 106:767–73.

14. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120:1640–5.
15. Lee YS, Hong N, Witanto JN, Choi YR, Park J, Decazes P, et al. Deep neural network for automatic volumetric segmentation of whole-body CT images for body composition assessment. Clin Nutr. 2021; 40:5038–46.

16. Lee C, Kim JH, Moon SJ, Shim J, Kim HI, Choi MH. Selective LC-MRM/SIM-MS based profiling of adrenal steroids reveals metabolic signatures of 17α-hydroxylase deficiency. J Steroid Biochem Mol Biol. 2020; 198:105615.

17. Geraghty EM, Boone JM, McGahan JP, Jain K. Normal organ volume assessment from abdominal CT. Abdom Imaging. 2004; 29:482–90.

18. Schneller J, Reiser M, Beuschlein F, Osswald A, Pallauf A, Riester A, et al. Linear and volumetric evaluation of the adrenal gland: MDCT-based measurements of the adrenals. Acad Radiol. 2014; 21:1465–74.
19. Jaresch S, Kornely E, Kley HK, Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1992; 74:685–9.

20. Park BK, Kim B, Ko K, Jeong SY, Kwon GY. Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: pathological correlation. Eur Radiol. 2006; 16:642–7.

21. Park SY, Park BK, Park JJ, Kim CK. Differentiation of adrenal hyperplasia from adenoma by use of CT densitometry and percentage washout. AJR Am J Roentgenol. 2016; 206:106–12.

22. German-Mena E, Zibari GB, Levine SN. Adrenal myelolipomas in patients with congenital adrenal hyperplasia: review of the literature and a case report. Endocr Pract. 2011; 17:441–7.

23. McGeoch SC, Olson S, Krukowski ZH, Bevan JS. Giant bilateral myelolipomas in a man with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2012; 97:343–4.

24. Selye H, Stone H. Hormonally induced transformation of adrenal into myeloid tissue. Am J Pathol. 1950; 26:211–33.
25. Falhammar H, Filipsson Nystrom H, Wedell A, Thoren M. Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol. 2011; 164:285–93.
